Tower Research Capital (TRC)’s Comera Life Sciences Holdings, Inc. Common Stock CMRA Stock Holding History

Tower Research Capital (TRC)’s Portfolio CMRA Stock Details CMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,338	Closed	-$2.14K	–	6331
2023 Q3	$2.14K	Sell	7,338 -24	-0.3%	-$13	﹤0.01%	5207
2023 Q2	$3.58K	Buy	7,362 +1,796	+32%	+$1.15K	﹤0.01%	5049
2023 Q1	$5K	Buy	5,566 +4,272	+330%	+$5.37K	﹤0.01%	5026
2022 Q4	$2K	Sell	1,294 -1,590	-55%	-$2.32K	﹤0.01%	5478
2022 Q3	$5K	Sell	2,884 -35,570	-93%	-$85.1K	﹤0.01%	5197
2022 Q2	$102K	Buy	+38,454	New	+$127K	﹤0.01%	2281

Tower Research Capital (TRC)'s CMRA Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of Comera Life Sciences Holdings, Inc. Common Stock (CMRA) in Q4 2023, closing a stake of 7,338 shares — an estimated $2.14K sold.

Tower Research Capital (TRC) first reported a position in CMRA in Q2 2022 and held it in 6 quarters. The position peaked at $102K in Q2 2022. 0 funds tracked by Wall St. Rank hold CMRA as of Q4 2023.

Tower Research Capital (TRC) reported no remaining Comera Life Sciences Holdings, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 7,338 Comera Life Sciences Holdings, Inc. Common Stock shares in Q4 2023, an estimated $2.14K.
Tower Research Capital (TRC) first reported a position in Comera Life Sciences Holdings, Inc. Common Stock in Q2 2022 and held it in 6 quarters.
Tower Research Capital (TRC)'s Comera Life Sciences Holdings, Inc. Common Stock position peaked at $102K in Q2 2022.
0 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Common Stock as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.